(Q48833407)

16 February 2018

title

Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models (English)

1 reference

16 February 2018

0 references

1 reference

8

Manho Kim

1 reference

16 February 2018

Keun-Hwa Jung

4

Keun-Hwa Jung

1 reference

16 February 2018

Kon Chu

2

Kon Chu

1 reference

16 February 2018

Soon-Tae Lee

1

Soon-Tae Lee

1 reference

16 February 2018

Sang Kun Lee

7

Sang Kun Lee

1 reference

16 February 2018

Daejong Jeon

5

Daejong Jeon

1 reference

16 February 2018

Jae-Kyu Roh

9

Jae-Kyu Roh

1 reference

16 February 2018

author name string

Jung-Eun Park

3

1 reference

16 February 2018

Ji-Youn Lim

6

1 reference

16 February 2018

language of work or name

English

0 references

publication date

11 November 2011

1 reference

16 February 2018

Journal of Neurochemistry

published in

1 reference

16 February 2018

volume

120

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

115-124

1 reference

16 February 2018

Erythropoietin enhances hippocampal long-term potentiation and memory

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin reduces epileptogenic processes following status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Recombinant human erythropoietin in the treatment of acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Mechanisms of soluble beta-amyloid impairment of endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Ablation of Ca2+ channel beta3 subunit leads to enhanced N-methyl-D-aspartate receptor-dependent long term potentiation and improved long term memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Increased hippocampal neurogenesis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Alzheimer's disease, cerebrovascular dysfunction and the benefits of exercise: from vessels to neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Decreased number and function of endothelial progenitor cells in patients with migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Slowed progression in models of Huntington disease by adipose stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Reduced circulating angiogenic cells in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Derivatives of erythropoietin that are tissue protective but not erythropoietic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Beneficial effect of erythropoietin on experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Protective effect of erythropoietin on beta-amyloid-induced PC12 cell death through antioxidant mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Disturbed cross talk between insulin-like growth factor I and AMP-activated protein kinase as a possible cause of vascular dysfunction in the amyloid precursor protein/presenilin 2 mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Protective effects of erythropoietin on tau phosphorylation induced by beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

G-CSF rescues the memory impairment of animal models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin promotes survival of primary human endothelial cells through PI3K-dependent, NF-kappaB-independent upregulation of Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Neurovascular mechanisms of Alzheimer's neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07534.X

10.1111/J.1471-4159.2011.07534.X

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

release_zaovs65k25f4lndjd2opakpjja

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zaovs65k25f4lndjd2opakpjja

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

16 February 2018